Estimated prices of agents approved to treat prostate cancer

TreatmentCost of treatment aloneaMedian overall survival benefit
sipuleucel-T$93,000 (median 3 cycles)25.8 months vs. 21.7 months [9]
enzalutamide$89,952 (median of 8 cycles)18.4 months vs. 13.6 months [4]
abiraterone$144,950 (median of 14 cycles)34.7 vs. 30.3 months [6, 59]
docetaxel$25,000 (median of 10 cycles)18.9 months vs. 16.5 months [60]
cabazitaxel$68,751 (median of 6 cycles)15.1 months vs. 12.7 months [7]
radium-223$155,048 (median of 6 injections)14.9 months vs. 11.3 months [8]

aAs determined by using estimates of average wholesale drug prices retrieved from UptoDate accessed 11/17/2016